참고문헌
- C.B. Thomas, Familial and epidemiologic aspects of coronary disease and hypertension, J. Chron. Dis., 7, 198 (1958) https://doi.org/10.1016/0021-9681(58)90026-2
- M.M. Weir, J.F. Dunn and P.E. Buell, Smoking and oral cancer: epidemiological data, educational responses, Am. J. Public Health., 59(6), 959-966 (1969) https://doi.org/10.2105/AJPH.59.6.959
- E.N. Valentine, Squamous metaplasia of the brochus, Cancer, 10, 272-279 (1957) https://doi.org/10.1002/1097-0142(195703/04)10:2<272::AID-CNCR2820100209>3.0.CO;2-L
- S.C. Mulligan, J.G. Masterson, J.G. Devane and J.G. Kelly, Clinical and pharmacokinetic properties of a transdermal nicotine patch, Clin Pharmacol. Ther., 47(3), 331-337 (1990) https://doi.org/10.1038/clpt.1990.36
- S.K. Gupta, R.A. Okerholm, P. Coen, R.D. Prather and J. Gorsline, Single- and multiple-dose pharmacokinetics of nicoderm (Nicotine transdermal system), J. Clin Pharmacol., 33, 169-174 (1993) https://doi.org/10.1002/j.1552-4604.1993.tb03939.x
- K.K.H. Chan, H.D. Ross, B. Berner, A.J. Piraino and V.A. John, Pharmacokinetics of a single transdermal dose of nicotine in healthy smokers, J. Controlled Release, 14, 145-151 (1990) https://doi.org/10.1016/0168-3659(90)90151-I
- N.L. Benowitz, K. Chan, C.P. Denaro and P.I. Jacob III, Stable isotope method for studying trans dermal drug absorption : the nicotine patch, Clin. Pharmacol. Ther., 50(3),286-293 (1991) https://doi.org/10.1038/clpt.1991.138
- N.L, Benowitz, P.I. Jacob III, P. Olsson and C.J. Johansson, Intravenous nicotine retards transdermal absorption of nicotine : evidence of blood flow-limited percutaneous absorption, Clin. Pharmacol. Ther., 52(3) 223-230 (1992) https://doi.org/10.1038/clpt.1992.134
- G.M. Kochak, J.X. Sun, R.L. Choi and A.J. Piraino, Pharmacokinetic disposition of multiple-dose transdermal nicotine in healthy adult smokers, Pharm. Res., 9(11), 1451-1455 (1992) https://doi.org/10.1023/A:1015862930096
-
S. Caspary, B. Keller-Stanislawski, T. Huber and P.-G. Merz, Phannacokinetics of nicotine after application of a 30
$cm^2$ nicotine patch under steady-state conditions, Int. J. Clin. Pharmacol. Ther. Toxicol., 29(3),92-95 (1991) - S. Lin and Y.W. Chien, Transdermal nicotine delivery systems: multi-institutional cooperative bioequivalence studies, Drug Dev. Ind. Pharm., 19(20), 2765-2793 (1993) https://doi.org/10.3109/03639049309050177
- D.R. Plowchalk. M.E. Andersen and J.D. Debetbizy, A physiologically based pharmacokinetics model for niotine disposition in the Sprague-Dawley rat, Toxico. Appl. Pharmacol., 116, 177-188 (1992) https://doi.org/10.1016/0041-008X(92)90297-6
- G.A. Kyerematen, L.H. Taylor, J.D. Debethizy and E.S. Vesell, Phannacokinetics of nicotine and 12 metabolites in the rat, Drug Metab. Dispos. Biol. Chem., 16(1), 125-129 (1988)
- K.S. Rotenberg and J. Adir, Pharmacokinetics of nicotine in rats after multiple cigarette smoke exposure, Toxico. Appl. Pharmacol., 69, 1-11 (1983) https://doi.org/10.1016/0041-008X(83)90113-8
- K.S. Rotenberg, R.P. Miller and J. Adir, Pharmacokinetics of nicotine in rats after single-cigarette smoke inhalation, J. Pharm. Sci., 69(9), 1087-1090 (1980) https://doi.org/10.1002/jps.2600690927
- S.C. Shin and J.S. Choi, Enhanced bioavailability of triprolidine from the transdermal TPX matrix system in rabbits, Int. J. Pharm., 234(1-2), 67-73 (2002) https://doi.org/10.1016/S0378-5173(01)00960-7
- S.C. Shin and J.S. Choi, Enhanced bioavailability of atenolol by transdermal administration of the ethylene-vinyl acetate matrix in rabbits, Eur. J. Pharm. Biopharm., 56(3), 439-43 (2003) https://doi.org/10.1016/S0939-6411(03)00133-4
- B. W. Barry, Dermatological formulations, Marcel Dekker, Inc., New York (1983)
- V.P. Shah and H.I. Maibach, Topical drug bioavailability, bioequivalence, and penetration, Plenum, 29 (1993)
- C.-C. Chiang, Transdermal nicotine absorption dosage unit and process, WO 93/00057 (1993)